Lung Cancer Screening Prevalence and Changes in 2024
-
By
-
Todd Burus
-
Caree R. McAfee
-
Jennifer Redmond Knight
-
Timothy W. Mullett
-
Pamela C. Hull
-
June 1, 2026
-
Clinical Scorecard: Trends and Prevalence of Lung Cancer Screening in 2024
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | Annual screening with low-dose computed tomography for high-risk individuals as per USPSTF guidelines. |
| Target Population | Adults aged 50 to 80 years who are current smokers or have quit within 15 years, with a smoking history of 20 or more pack-years. |
| Care Setting | |
Key Highlights
- 24.49% of eligible respondents were up-to-date on screenings in 2024.
- UTD prevalence increased by 6.00 percentage points since 2022.
- Significant increases in UTD prevalence among individuals with military-related insurance.
- State-level UTD prevalence ranged from 13.43% in South Dakota to 38.36% in Massachusetts.
Guideline-Based Recommendations
Diagnosis
- Annual lung cancer screening for eligible individuals as per USPSTF guidelines.
Management
- Utilize low-dose computed tomography for screening.
Monitoring & Follow-up
- Track screening uptake and prevalence across demographics and regions.
Risks
- Potential biases in self-reported data and exclusion of adults aged 80 years.
Patient & Prescribing Data
Adults aged 50 to 80 years with specific smoking histories.
Clinical Best Practices
Related Resources & Content
